PYC Therapeutics Limited

ASX:PYC.AX

0.19 (AUD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q22008 Q12007 Q42007 Q32007 Q22007 Q12006 Q42006 Q32006 Q22006 Q12005 Q42005 Q32005 Q2
Revenue 13.1528.90712.3343.47210.0485.9943.07402.3960-000.0080.040.0022.760.00100.0530.776-0.0080.7470.61400.0980.480.480.480.480.590.590.590.590.1490.1490.1490.1490.3190.3190.3190.3190.0230.0230.0230.0230.0690.0690.0690.06900000.0130.0130.0130.013
Cost of Revenue 0.7310.3360.0940.4580.4160.4240.3350.2870.3050.2420.092.8414.0392.9242.4552.2172.5041.9011.7671.8121.891.731.69301.574000000000000000000000.0680.0680.0680.0680.0340.0340.0340.0340000
Gross Profit 12.4218.57112.2413.0149.6335.572.739-0.2872.09-0.242-0.091-2.84-4.031-2.884-2.4520.543-2.503-1.901-1.714-1.036-1.897-0.983-1.0790-1.4760.480.480.480.480.590.590.590.590.1490.1490.1490.1490.3190.3190.3190.3190.0230.0230.0230.0230.0010.0010.0010.001-0.034-0.034-0.034-0.0340.0130.0130.0130.013
Gross Profit Ratio 0.9440.9620.9920.8680.9590.9290.89100.8730362.728-11,361.548-476.43-72.089-990.8140.197-2,391.059-65,544.31-32.109-1.335241.796-1.315-1.7570-15.053111111111111111111110.010.010.010.0100001111
Reseach & Development Expenses 34.56121.84817.19817.94814.6479.3845.8220.0070.7030.0231.7512.7893.9112.8362.5242.1482.9931.862.4021.7132.6331.5432.54101.50100000000000000000.5710.5710.5710.57100000.3440.3440.3440.3440.1020.1020.1020.102
General & Administrative Expenses 2.0132.4951.6222.4693.1133.1855.0472.7823.4710.3470.1260.2840.7621.9210.590.4480.0840.2320.2660.2760.1540.280.2080.3880.3260.3470.3470.3470.3470.3820.3820.3820.3820.3410.3410.3410.3410.3370.3370.3370.3370.5060.5060.5060.5060.4780.4780.4780.4780.4020.4020.4020.4020.3150.3150.3150.315
Selling & Marketing Expenses 0-0.336-0.094-0.458-0.416-0.4242.7884.7640.6183.9931.1730.645-0.6010.820.3840.4310.5520.5560.710.6040.6520.7160.6830.6830.6830.7530.7530.7530.7530.7160.7160.7160.7160.6170.6170.6170.6170.5420.5420.5420.54200000.2130.2130.2130.2130.0050.0050.0050.0050000
SG&A 2.0132.1591.5292.0112.6972.7617.8357.5464.0894.341.3640.9290.1612.7420.9740.8780.6360.7880.9760.880.8050.9971.021.071.321.11.11.11.11.0981.0981.0981.0980.9580.9580.9580.9580.8790.8790.8790.879-0.244-0.244-0.244-0.2440.6910.6910.6910.6910.4070.4070.4070.407-0.081-0.081-0.081-0.081
Other Expenses 0000003.075000000000000000000000000000000000000000000-0.522-0.522-0.522-0.5220000
Operating Expenses 36.57424.00618.72719.95917.34412.14510.5837.5534.7924.3623.1151.0560.0742.8791.3021.040.8141.0071.1731.1111.0411.2151.2411.071.5971.11.11.11.11.0981.0981.0981.0980.9580.9580.9580.9580.8790.8790.8790.8790.3270.3270.3270.3270.6910.6910.6910.6910.2290.2290.2290.2290.0210.0210.0210.021
Operating Income -23.422-24.343-18.821-20.417-17.76-12.569-10.918-7.84-5.098-4.604-3.205-3.897-3.957-5.763-3.754-0.497-3.317-2.907-2.887-2.146-2.938-2.198-2.32-1.526-3.073-1.017-1.017-1.017-1.017-0.929-0.929-0.929-0.929-1.166-1.166-1.166-1.166-0.926-0.926-0.926-0.926-1.393-1.393-1.393-1.393-1.174-1.174-1.174-1.174-1.019-1.019-1.019-1.019-0.425-0.425-0.425-0.425
Operating Income Ratio -1.781-2.733-1.526-5.88-1.767-2.097-3.5510-2.128012,820-15,586.736-467.696-144.075-1,516.826-0.18-3,168.313-100,254.276-54.097-2.767374.416-2.942-3.7790-31.339-2.12-2.12-2.12-2.12-1.576-1.576-1.576-1.576-7.823-7.823-7.823-7.823-2.904-2.904-2.904-2.904-61.418-61.418-61.418-61.418-17.052-17.052-17.052-17.0520000-32.32-32.32-32.32-32.32
Total Other Income Expenses Net 0.5680.1790.0710.003-0.0150.0770.0410.0870.1910.0360.0710.0470.0430.0710.0370.0390.0840.0950.030.0450.0740.0130.0380.1960.0360.040.040.040.040.0280.0280.0280.0280.0230.0230.0230.023-0.197-0.197-0.197-0.1970.2720.2720.2720.2720.2020.2020.2020.202-0.05-0.05-0.05-0.050.0280.0280.0280.028
Income Before Tax -22.854-24.164-18.749-20.413-17.775-12.492-10.877-7.753-4.907-4.568-3.134-3.85-3.913-5.691-3.718-0.458-3.233-2.813-2.857-2.101-2.865-2.185-2.282-1.33-3.037-0.976-0.976-0.976-0.976-0.901-0.901-0.901-0.901-1.143-1.143-1.143-1.143-1.123-1.123-1.123-1.123-1.121-1.121-1.121-1.121-0.972-0.972-0.972-0.972-1.069-1.069-1.069-1.069-0.397-0.397-0.397-0.397
Income Before Tax Ratio -1.738-2.713-1.52-5.879-1.769-2.084-3.5380-2.048012,536-15,398.696-462.568-142.287-1,502.064-0.166-3,088.216-96,984.759-53.527-2.709365.046-2.924-3.7170-30.973-2.035-2.035-2.035-2.035-1.529-1.529-1.529-1.529-7.669-7.669-7.669-7.669-3.522-3.522-3.522-3.522-49.409-49.409-49.409-49.409-14.121-14.121-14.121-14.1210000-30.203-30.203-30.203-30.203
Income Tax Expense -8.652-8.907-12.334-3.472-9.975-5.998-0.479-0.3832.396-2.396-02.90402.1712.225002.06701.96601.792-0.47-0.471.8790.040.040.040.040.0280.0280.0280.0280.0230.0230.0230.023-0.197-0.197-0.197-0.1970.2720.2720.2720.2720.2020.2020.2020.202-0.072-0.072-0.072-0.072-0.397-0.397-0.397-0.397
Net Income -22.631-15.095-6.55-16.239-7.445-6.418-10.398-7.37-4.721-2.101-3.134-0.946-3.913-3.521-1.493-0.458-3.233-0.745-2.857-0.135-2.865-0.393-2.282-0.86-1.158-0.976-0.976-0.976-0.976-0.901-0.901-0.901-0.901-1.143-1.143-1.143-1.143-1.123-1.123-1.123-1.123-1.121-1.121-1.121-1.121-0.972-0.972-0.972-0.972-0.998-0.998-0.998-0.998-0.397-0.397-0.397-0.397
Net Income Ratio -1.721-1.695-0.531-4.677-0.741-1.071-3.3820-1.971012,536-3,782.216-462.568-88.017-603.112-0.166-3,088.216-25,700.345-53.527-0.174365.046-0.526-3.7170-11.808-2.035-2.035-2.035-2.035-1.529-1.529-1.529-1.529-7.669-7.669-7.669-7.669-3.522-3.522-3.522-3.522-49.409-49.409-49.409-49.409-14.121-14.121-14.121-14.1210000-30.203-30.203-30.203-30.203
EPS -0.006-0.004-0.002-0.005-0.002-0.002-0.003-0.002-0.002-0.001-0.001-0-0.002-0.002-0.001-0-0.002-0-0.003-0-0.003-0.001-0.005-0.001-0.003-0.002-0-0.002-0-0.002-0-0.002-0-0.004-0-0.004-0-0.005-0-0.005-0-0.006-0-0.006-0-0.006-0-0.006-0-0.007-0-0.007-0-0.005-0-0.005-0
EPS Diluted -0.006-0.004-0.002-0.005-0.002-0.002-0.003-0.002-0.002-0.001-0.001-0-0.002-0.002-0.001-0-0.002-0-0.003-0-0.003-0.001-0.005-0.001-0.003-0.002-0-0.002-0-0.002-0-0.002-0-0.004-0-0.004-0-0.005-0-0.005-0-0.006-0-0.006-0-0.006-0-0.006-0-0.007-0-0.007-0-0.005-0-0.005-0
EBITDA -23.019-24.006-18.727-19.959-17.344-12.145-10.583-7.553-4.792-4.362-3.115-3.857-3.917-5.722-3.735-0.461-3.269-2.833-2.792-2.029-2.829-2.093-2.183-1.261-2.936-0.927-0.927-0.927-0.927-0.863-0.863-0.863-0.863-1.126-1.126-1.126-1.126-1.094-1.094-1.094-1.094-1.109-1.109-1.109-1.109-0.966-0.966-0.966-0.966-1.065-1.065-1.065-1.065-0.794-0.794-0.794-0.794
EBITDA Ratio -1.75-2.695-1.518-5.748-1.726-2.026-3.4420-2012,458-15,426.24-462.986-143.038-1,509.163-0.167-3,122.584-97,694.414-52.322-2.615360.499-2.801-3.5560-29.941-1.933-1.933-1.933-1.933-1.463-1.463-1.463-1.463-7.557-7.557-7.557-7.557-3.433-3.433-3.433-3.433-48.864-48.864-48.864-48.864-14.025-14.025-14.025-14.0250000-60.405-60.405-60.405-60.405